The present invention provides a method for inhibiting immunoglobulin-induced toxicity resulting from immunotherapy in a subject comprising administering an immunoglobulin or Ig fusion protein molecule to the subject, the immunoglobulin molecule having a variable region and a constant region, the immunoglobulin molecule being modified prior to administration by inactivation of at least a portion of the constant region.

 
Web www.patentalert.com

> Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations

~ 00365